Tailored immunosuppression in biopsy-proven immune-mediated myocarditis
- PMID: 38700444
- DOI: 10.1002/ejhf.3276
Tailored immunosuppression in biopsy-proven immune-mediated myocarditis
References
-
- Ammirati E, Frigerio M, Adler ED, Basso C, Birnie DH, Brambatti M, et al. Management of acute myocarditis and chronic inflammatory cardiomyopathy: An expert consensus document. Circ Heart Fail 2020;13:e007405. https://doi.org/10.1161/CIRCHEARTFAILURE.120.007405
-
- Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno‐Blanes J, Felix SB, et al.; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:2636–2648. https://doi.org/10.1093/eurheartj/eht210
-
- Seferović PM, Tsutsui H, McNamara DM, Ristić AD, Basso C, Bozkurt B, et al. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy. Eur J Heart Fail 2021;23:854–871. https://doi.org/10.1002/ejhf.2190
-
- Aretz HT. Myocarditis: The Dallas criteria. Hum Pathol 1987;18:619–624. https://doi.org/10.1016/S0046‐8177(87)80363‐5
-
- Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269–275. https://doi.org/10.1056/NEJM199508033330501
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources